These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Smits P; Williams SB; Lipson DE; Banitt P; Rongen GA; Creager MA Circulation; 1995 Oct; 92(8):2135-41. PubMed ID: 7554193 [TBL] [Abstract][Full Text] [Related]
27. Role of nitric oxide synthase in release of endothelin from cultured human endometrial cells. Lin Z; Kubota T; Masuda M; Aso T Eur J Endocrinol; 1998 Apr; 138(4):467-71. PubMed ID: 9578518 [TBL] [Abstract][Full Text] [Related]
28. Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men. Nietlispach F; Julius B; Schindler R; Bernheim A; Binkert C; Kiowski W; Brunner-La Rocca HP Hypertension; 2007 Jul; 50(1):82-8. PubMed ID: 17502494 [TBL] [Abstract][Full Text] [Related]
29. Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity. Schinzari F; Tesauro M; Veneziani A; Mores N; Di Daniele N; Cardillo C Hypertension; 2018 Jan; 71(1):185-191. PubMed ID: 29203627 [TBL] [Abstract][Full Text] [Related]
30. Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxide. Avogaro A; Calò L; Piarulli F; Miola M; deKreutzenberg S; Maran A; Burlina A; Mingardi R; Tiengo A; Del Prato S Diabetes; 1999 Feb; 48(2):391-7. PubMed ID: 10334319 [TBL] [Abstract][Full Text] [Related]
31. Prostaglandins and nitric oxide mediate insulin-induced vasodilation in the human forearm. van Veen S; Chang PC Cardiovasc Res; 1997 Apr; 34(1):223-9. PubMed ID: 9217894 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of nitric oxide and prostaglandins, but not endothelial-derived hyperpolarizing factors, reduces blood flow and aerobic energy turnover in the exercising human leg. Mortensen SP; González-Alonso J; Damsgaard R; Saltin B; Hellsten Y J Physiol; 2007 Jun; 581(Pt 2):853-61. PubMed ID: 17347273 [TBL] [Abstract][Full Text] [Related]
33. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia. Pickkers P; Dorresteijn MJ; Bouw MP; van der Hoeven JG; Smits P Circulation; 2006 Aug; 114(5):414-21. PubMed ID: 16864730 [TBL] [Abstract][Full Text] [Related]
34. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1. Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766 [TBL] [Abstract][Full Text] [Related]
35. Vascular Effects of Obestatin in Lean and Obese Subjects. Schinzari F; Veneziani A; Mores N; Barini A; Di Daniele N; Cardillo C; Tesauro M Diabetes; 2017 May; 66(5):1214-1221. PubMed ID: 28174289 [TBL] [Abstract][Full Text] [Related]
36. Ageing is associated with impairment of nitric oxide and prostanoid dilator pathways in the human forearm. Singh N; Prasad S; Singer DR; MacAllister RJ Clin Sci (Lond); 2002 May; 102(5):595-600. PubMed ID: 11980580 [TBL] [Abstract][Full Text] [Related]
37. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis. Böhm F; Ahlborg G; Pernow J Clin Sci (Lond); 2002 Mar; 102(3):321-7. PubMed ID: 11869173 [TBL] [Abstract][Full Text] [Related]
38. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Dawes M; Chowienczyk PJ; Ritter JM Circulation; 1997 May; 95(9):2293-7. PubMed ID: 9142007 [TBL] [Abstract][Full Text] [Related]
39. Vasodilator responses in the forearm skin of patients with insulin-dependent diabetes mellitus. Khan F; Cohen RA; Ruderman NB; Chipkin SR; Coffman JD Vasc Med; 1996; 1(3):187-93. PubMed ID: 9546937 [TBL] [Abstract][Full Text] [Related]
40. Effects of Intrabrachial metacholine infusion on muscle capillary recruitment and forearm glucose uptake during physiological hyperinsulinemia in obese, insulin-resistant individuals. Murdolo G; Sjöstrand M; Strindberg L; Gudbjörnsdóttir S; Lind L; Lönnroth P; Jansson PA J Clin Endocrinol Metab; 2008 Jul; 93(7):2764-73. PubMed ID: 18460559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]